Insider · CIK 0002065241
Steven C. Crouse
Files at TECH (BIO-TECHNE Corp), OABI (OmniAb, Inc.). First filing -, latest -.
In brief
Steven C. Crouse files SEC Form 4 as director and president at TECH (BIO-TECHNE Corp), and also at OABI (OmniAb, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Steven C. Crouse has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 26 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | TECH BIO-TECHNE Corp | AGrant or award Restricted Stock Unitsderivative | +8,702 | $0.00 | $0 | 8,702 | Aug 19, 2026 |
| Aug 17, 2026 | TECH BIO-TECHNE Corp | AGrant or award Restricted Stock Unitsderivative | +14,140 | $0.00 | $0 | 14,140 | Aug 19, 2026 |
| Aug 15, 2026 | TECH BIO-TECHNE Corp | MOption exercise Common Stock | +5,423 | $0.00 | $0 | 12,184 | Aug 18, 2026 |
| Aug 15, 2026 | TECH BIO-TECHNE Corp | FTax withholding Common Stock | -1,947 | $72.40 | $141k | 10,237 | Aug 18, 2026 |
| Aug 15, 2026 | TECH BIO-TECHNE Corp | MOption exercise Restricted Stock Unitsderivative | -1,379 | $0.00 | $0 | 0 | Aug 18, 2026 |
| Aug 15, 2026 | TECH BIO-TECHNE Corp | MOption exercise Restricted Stock Unitsderivative | -1,868 | $0.00 | $0 | 1,869 | Aug 18, 2026 |
| Aug 15, 2026 | TECH BIO-TECHNE Corp | MOption exercise Restricted Stock Unitsderivative | -2,176 | $0.00 | $0 | 4,353 | Aug 18, 2026 |
| Jun 17, 2026 | OABI OmniAb, Inc. | MOption exercise Common Stock | +20,000 | - | - | 33,333 | Jun 18, 2026 |
| Jun 17, 2026 | OABI OmniAb, Inc. | MOption exercise Restricted Stock Unitsderivative | -20,000 | $0.00 | $0 | 26,667 | Jun 18, 2026 |
| Jun 17, 2026 | OABI OmniAb, Inc. | AGrant or award Restricted Stock Unitsderivative | +20,000 | $0.00 | $0 | 46,667 | Jun 18, 2026 |
| Jun 17, 2026 | OABI OmniAb, Inc. | AGrant or award Stock Option (right to buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jun 18, 2026 |
| Jun 2, 2026 | TECH BIO-TECHNE Corp | MOption exercise Common Stock | +600 | - | - | 6,977 | Jun 4, 2026 |
| Jun 2, 2026 | TECH BIO-TECHNE Corp | FTax withholding Common Stock | -216 | $49.77 | $11k | 6,761 | Jun 4, 2026 |
| Jun 2, 2026 | TECH BIO-TECHNE Corp | MOption exercise Restricted Stock Unitsderivative | -600 | $0.00 | $0 | 1,200 | Jun 4, 2026 |
| May 1, 2026 | TECH BIO-TECHNE Corp | MOption exercise Common Stock | +794 | - | - | 6,688 | May 5, 2026 |
| May 1, 2026 | TECH BIO-TECHNE Corp | FTax withholding Common Stock | -311 | $55.02 | $17k | 6,337 | May 5, 2026 |
| May 1, 2026 | TECH BIO-TECHNE Corp | MOption exercise Restricted Stock Unitsderivative | -794 | $0.00 | $0 | 794 | May 5, 2026 |
| Apr 21, 2026 | OABI OmniAb, Inc. | MOption exercise Common Stock | +13,333 | - | - | 13,333 | Apr 21, 2026 |
| Apr 21, 2026 | OABI OmniAb, Inc. | MOption exercise Restricted Stock Unitsderivative | -13,333 | $0.00 | $0 | 46,667 | Apr 21, 2026 |
| Mar 2, 2026 | TECH BIO-TECHNE Corp | AGrant or award Performance Restricted Stock Unitsderivative | +2,387 | $0.00 | $0 | 2,387 | Mar 4, 2026 |
| Mar 2, 2026 | TECH BIO-TECHNE Corp | AGrant or award Restricted Stock Unitsderivative | +735 | $0.00 | $0 | 735 | Mar 4, 2026 |
| Mar 2, 2026 | TECH BIO-TECHNE Corp | AGrant or award Stock Option (right to buy)derivative | +1,911 | $0.00 | $0 | 1,911 | Mar 4, 2026 |
| Jun 17, 2025 | OABI OmniAb, Inc. | AGrant or award Restricted Stock Unitsderivative | +20,000 | $0.00 | $0 | 60,000 | Jun 18, 2025 |
| Jun 17, 2025 | OABI OmniAb, Inc. | AGrant or award Stock Option (right to buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jun 18, 2025 |
| Apr 21, 2025 | OABI OmniAb, Inc. | AGrant or award Restricted Stock Unitsderivative | +40,000 | $0.00 | $0 | 40,000 | Apr 21, 2025 |
| Apr 21, 2025 | OABI OmniAb, Inc. | AGrant or award Stock Option (right to buy)derivative | +80,000 | $0.00 | $0 | 80,000 | Apr 21, 2025 |
Questions about Steven C. Crouse
Answered from the filings on this page, as of the latest one.
Is Steven C. Crouse buying or selling?
Steven C. Crouse has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Steven C. Crouse's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Steven C. Crouse has 0.
Where does Steven C. Crouse file Form 4?
Steven C. Crouse has filed Form 4 at TECH (BIO-TECHNE Corp) as President - Diag & Spatial Bi; OABI (OmniAb, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.